X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17794) 17794
Publication (3095) 3095
Book Review (94) 94
Book Chapter (46) 46
Conference Proceeding (27) 27
Dissertation (15) 15
Reference (3) 3
Book / eBook (2) 2
Data Set (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (11059) 11059
index medicus (9976) 9976
humans (9699) 9699
mice (5303) 5303
phosphorylation (5082) 5082
mitogen-activated protein kinases - metabolism (4563) 4563
rats (4197) 4197
cell biology (3974) 3974
cells, cultured (3965) 3965
signal transduction (3924) 3924
male (3844) 3844
biochemistry & molecular biology (3706) 3706
p38 mitogen-activated protein kinases - metabolism (3623) 3623
enzyme inhibitors - pharmacology (3483) 3483
apoptosis (3308) 3308
signal transduction - drug effects (3098) 3098
mitogen-activated protein kinase 1 - metabolism (3001) 3001
expression (2928) 2928
activation (2901) 2901
cell line, tumor (2556) 2556
female (2523) 2523
mitogen-activated protein kinase 3 - metabolism (2508) 2508
cell line (2500) 2500
p38 mitogen-activated protein kinases - antagonists & inhibitors (2397) 2397
mitogen-activated protein kinases - antagonists & inhibitors (2365) 2365
phosphorylation - drug effects (2277) 2277
apoptosis - drug effects (2111) 2111
map kinase (2083) 2083
protein kinase inhibitors - pharmacology (2081) 2081
oncology (2036) 2036
kinases (2033) 2033
activated protein-kinase (2008) 2008
pharmacology & pharmacy (1941) 1941
proteins (1923) 1923
jnk mitogen-activated protein kinases - metabolism (1884) 1884
blotting, western (1751) 1751
neurosciences (1746) 1746
imidazoles - pharmacology (1725) 1725
enzyme activation - drug effects (1716) 1716
pyridines - pharmacology (1708) 1708
rats, sprague-dawley (1688) 1688
protein kinases (1676) 1676
enzyme activation (1666) 1666
map kinase signaling system - drug effects (1666) 1666
gene-expression (1651) 1651
article (1639) 1639
dose-response relationship, drug (1599) 1599
inflammation (1549) 1549
cell proliferation - drug effects (1452) 1452
cancer (1447) 1447
research (1416) 1416
cells (1382) 1382
gene expression (1368) 1368
nf-kappa-b (1364) 1364
flavonoids - pharmacology (1360) 1360
immunology (1326) 1326
physiology (1320) 1320
nf-kappa b - metabolism (1319) 1319
oxidative stress (1285) 1285
inhibition (1258) 1258
in-vitro (1244) 1244
analysis (1228) 1228
signal transduction - physiology (1227) 1227
time factors (1215) 1215
proto-oncogene proteins c-akt - metabolism (1159) 1159
pathway (1149) 1149
phosphatidylinositol 3-kinases - metabolism (1137) 1137
research article (1136) 1136
mitogen-activated protein kinase kinases - metabolism (1133) 1133
extracellular signal-regulated map kinases - metabolism (1132) 1132
mitogen-activated protein kinase 1 - antagonists & inhibitors (1132) 1132
mitogen-activated protein kinase (1113) 1113
jnk mitogen-activated protein kinases - antagonists & inhibitors (1111) 1111
cell survival - drug effects (1098) 1098
rna, messenger - metabolism (1093) 1093
endocrinology & metabolism (1088) 1088
mice, inbred c57bl (1082) 1082
physiological aspects (1078) 1078
p38 mitogen-activated protein kinases (1046) 1046
proliferation (1006) 1006
mitogen-activated protein kinase kinases - antagonists & inhibitors (1003) 1003
mapk (958) 958
in-vivo (950) 950
multidisciplinary sciences (945) 945
transfection (945) 945
cell proliferation (941) 941
protein-kinase (938) 938
signal-transduction (932) 932
kinase (916) 916
mitogen-activated protein kinase 3 - antagonists & inhibitors (912) 912
cytokines (886) 886
disease models, animal (886) 886
up-regulation (881) 881
extracellular signal-regulated kinase (879) 879
rodents (873) 873
mitogens (870) 870
reactive oxygen species - metabolism (869) 869
p38 mapk (866) 866
medicine (854) 854
growth (844) 844
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 4/2011, Volume 332, Issue 6027, pp. 358 - 361
Transforming growth factor—β (TGFβ) signaling drives aneurysm progression in multiple disorders, including Marfan syndrome (MFS), and therapies that inhibit... 
Transcriptional regulatory elements | Echocardiography | Aortic diseases | Root growth | REPORTS | Placebos | Aneurysms | Aorta | Mice | Aortic aneurysm | Marfan syndrome | PATHOGENESIS | CELLS | ACTIVATION | VALSALVA | MULTIDISCIPLINARY SCIENCES | N-TERMINAL KINASE | MOUSE MODEL | NOONANS-SYNDROME | RECEPTOR | MUTATIONS | INHIBITOR | Diphenylamine - pharmacology | Aortic Aneurysm - metabolism | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Anthracenes - therapeutic use | MAP Kinase Signaling System | Diphenylamine - analogs & derivatives | Marfan Syndrome - drug therapy | Smad4 Protein - genetics | Transforming Growth Factor beta - antagonists & inhibitors | Aortic Aneurysm - pathology | Aortic Aneurysm - prevention & control | Disease Models, Animal | Transforming Growth Factor beta - immunology | Diphenylamine - therapeutic use | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 8 - metabolism | Aortic Aneurysm - physiopathology | Losartan - pharmacology | Smad2 Protein - metabolism | Sulfonamides - pharmacology | Anthracenes - pharmacology | Disease Progression | Aorta - pathology | Animals | Mitogen-Activated Protein Kinase 3 - metabolism | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Losartan - therapeutic use | Marfan Syndrome - metabolism | Marfan Syndrome - pathology | Protein Kinase Inhibitors - pharmacology | Smad4 Protein - deficiency | Enzyme Activation | Transforming Growth Factor beta - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0124007
Cell invasion is a crucial mechanism of cancer metastasis and malignancy. Matrix metallo-proteinase-9 (MMP-9) is an important proteolytic enzyme involved in... 
MATRIX METALLOPROTEINASES | ANGIOGENESIS | NUCLEAR-FACTOR | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | INDUCED MATRIX-METALLOPROTEINASE-9 EXPRESSION | CYCLOOXYGENASE-2 EXPRESSION | PROLIFERATION | FOS | C-JUN | NF-KAPPA-B | Phosphorylation | Epithelial Cells - metabolism | Tetradecanoylphorbol Acetate - pharmacology | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Transcription Factor AP-1 - genetics | Epithelial Cells - drug effects | Humans | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Gene Expression Regulation, Neoplastic | Gastric Mucosa - metabolism | Mitogen-Activated Protein Kinase 9 - genetics | Tetradecanoylphorbol Acetate - antagonists & inhibitors | Transcription Factor AP-1 - metabolism | Dose-Response Relationship, Drug | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 9 - genetics | Oligodeoxyribonucleotides - genetics | Mitogen-Activated Protein Kinase 1 - genetics | Mitogen-Activated Protein Kinase 8 - genetics | Flavonoids - pharmacology | Stomach - drug effects | Oligodeoxyribonucleotides - metabolism | Stomach - pathology | Mitogen-Activated Protein Kinase 3 - genetics | Signal Transduction | Mitogen-Activated Protein Kinase 9 - metabolism | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 8 - metabolism | Proto-Oncogene Proteins c-fos - metabolism | Epithelial Cells - pathology | Antibodies - pharmacology | Cell Movement - drug effects | Transcription Factor AP-1 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 3 - metabolism | Mitogen-Activated Protein Kinase 9 - antagonists & inhibitors | Cell Line, Tumor | Proto-Oncogene Proteins c-fos - genetics | Antineoplastic Agents, Phytogenic - pharmacology | Mitogen-Activated Protein Kinase 1 - metabolism | Enzymes | Care and treatment | Oligodeoxynucleotides | Stomach cancer | Cancer cells | Cancer | Transcription factors | Oligonucleotides | Malignancy | Metastasis | Matrix metalloproteinase | Kinases | Cancer therapies | Medical schools | Western blotting | Metastases | Anticancer properties | Angiogenesis | Signal transduction | Pathways | Fos protein | Proteolysis | Metalloproteinase | c-Fos protein | Gastric cancer | Invasiveness | Extracellular signal-regulated kinase | c-Jun protein | Blocking | Breast cancer | Gene expression | Gelatinase B | Polymerase chain reaction | Signaling | Acetic acid
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 06/2016, Volume 36, Issue 6, pp. 1122 - 1131
OBJECTIVE—The c-Jun NH2-terminal kinases (JNK) are regulated by a wide variety of cellular stresses and have been implicated in apoptotic signaling.... 
atherosclerosis | apoptosis | macrophages | MAP kinase signaling system | endoplasmic reticulum stress | SURVIVAL | ACTIVATION | PHOSPHORYLATION | BAD | SIGNAL-TRANSDUCTION | OBESITY | NH2-TERMINAL KINASE (JNK)1 | INSULIN-RESISTANCE | INFLAMMATION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | REQUIREMENT | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Apoptosis - drug effects | Bone Marrow Cells - enzymology | Atherosclerosis - genetics | Mitogen-Activated Protein Kinase 9 - genetics | PTEN Phosphohydrolase - antagonists & inhibitors | Atherosclerosis - enzymology | Hypercholesterolemia - enzymology | Diet, High-Fat | Bone Marrow Transplantation | Receptors, LDL - deficiency | bcl-Associated Death Protein - metabolism | Bone Marrow Cells - drug effects | Mitogen-Activated Protein Kinase 8 - genetics | Aortic Diseases - enzymology | Proto-Oncogene Proteins c-akt - metabolism | Aorta - enzymology | Aortic Diseases - pathology | Disease Models, Animal | Receptors, LDL - genetics | Atherosclerosis - pathology | Genetic Predisposition to Disease | Macrophages - pathology | Signal Transduction | Cell Survival | Aorta - drug effects | Mice, Inbred C57BL | Bone Marrow Cells - pathology | Cells, Cultured | PTEN Phosphohydrolase - metabolism | Plaque, Atherosclerotic | Mitogen-Activated Protein Kinase 9 - deficiency | Macrophages - enzymology | Mice, Knockout | Aorta - pathology | Mitogen-Activated Protein Kinase 8 - deficiency | Aortic Diseases - genetics | Phenotype | Animals | Endoplasmic Reticulum Stress | Mitogen-Activated Protein Kinase 9 - antagonists & inhibitors | Macrophages - drug effects | Protein Kinase Inhibitors - pharmacology | Hypercholesterolemia - genetics
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2009, Volume 284, Issue 19, pp. 13165 - 13173
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 01/2018, Volume 44, Issue 5, pp. 1842 - 1855
Background/Aims: GLP-1 and ghrelin are common appetite-regulating hormones. Both have multiple functions beyond metabolic regulation. However, the effects of... 
Original Paper | Senescence | Glp-1 | Ghrelin | Microvascular endothelial cells | Apoptosis | OXIDATIVE STRESS | PHYSIOLOGY | ANGIOGENESIS | RECEPTOR | CARDIOMYOCYTES | CELL BIOLOGY | ANALOG LIRAGLUTIDE PROTECTS | PI3K/AKT SIGNALING PATHWAY | TNF-ALPHA | DYSFUNCTION | EXPRESSION | PROMOTES | Reactive Oxygen Species - metabolism | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Apoptosis - drug effects | Humans | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Caspase 3 - metabolism | Cellular Senescence - drug effects | Lipids - pharmacology | p38 Mitogen-Activated Protein Kinases - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Microvessels - cytology | Endothelial Cells - metabolism | Mitogen-Activated Protein Kinase 9 - metabolism | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 8 - metabolism | Cells, Cultured | Glucagon-Like Peptide 1 - pharmacology | Ghrelin - pharmacology | Glucose - pharmacology | Mitochondria - metabolism | Mitochondria - drug effects | Poly(ADP-ribose) Polymerases - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Endothelial Cells - cytology | Mitogen-Activated Protein Kinase 9 - antagonists & inhibitors | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Mitogen-Activated Protein Kinase 1 - metabolism | Diabetic retinopathy | Neurosciences | Cardiomyocytes | Lipids | Metabolism | Kinases | Experiments | Angiogenesis | Cell growth | Nitric oxide | Rodents | Atherosclerosis | Diabetes
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 4, pp. 968 - 981
Background & Aims c-Jun N-terminal kinase (JNK) 1 and JNK2 are expressed in hepatocytes and have overlapping and distinct functions. JNK proteins are activated... 
Gastroenterology and Hepatology | APAP | Gene Regulation | Pharmacologic Treatment | Mouse Model | APOPTOSIS | ACETAMINOPHEN-INDUCED HEPATOTOXICITY | OXIDATIVE STRESS | ACTIVATION | MOUSE HEPATOCYTES | TERMINAL KINASE | SIGNAL-TRANSDUCTION | MITOCHONDRIAL PERMEABILITY TRANSITION | NECROSIS | INHIBITION | GASTROENTEROLOGY & HEPATOLOGY | AMP-Activated Protein Kinases - metabolism | Phosphorylation | Cell Proliferation | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Oxidative Stress | Carbon Tetrachloride | Humans | Middle Aged | Liver Failure, Acute - enzymology | Hepatocytes - pathology | Male | Gene Expression Profiling | Mitogen-Activated Protein Kinase 9 - genetics | Case-Control Studies | Young Adult | Time Factors | Liver Failure, Acute - genetics | Cell Death | Female | Mitogen-Activated Protein Kinase 8 - genetics | Liver Failure, Acute - prevention & control | Chemical and Drug Induced Liver Injury - pathology | Chemical and Drug Induced Liver Injury - enzymology | Hepatocytes - drug effects | Disease Models, Animal | Chemical and Drug Induced Liver Injury - prevention & control | Signal Transduction | Mitogen-Activated Protein Kinase 9 - metabolism | Mice, Inbred C57BL | Mitogen-Activated Protein Kinase 8 - metabolism | Cells, Cultured | Liver Failure, Acute - chemically induced | Chemical and Drug Induced Liver Injury - genetics | Mitogen-Activated Protein Kinase 9 - deficiency | Mice, Knockout | Mitogen-Activated Protein Kinase 8 - deficiency | Animals | Acetaminophen | Liver Failure, Acute - pathology | Mitogen-Activated Protein Kinase 9 - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Hepatocytes - enzymology | Proteins | Medical colleges | Liver diseases | Liver | Carbon tetrachloride | Physiological aspects | Index Medicus | Abridged Index Medicus | pharmacological treatment | mouse model | gene regulation
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 01/2013, Volume 288, Issue 3, pp. 1883 - 1895
The JNK family of MAPKs is involved in a large variety of physiological and pathological processes in brain development, such as neural survival, migration,... 
GENETIC-ANALYSIS | PROTEIN | DCC | COLORECTAL-CANCER | COMMISSURAL AXONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECEPTOR | FOCAL ADHESION KINASE | DISTINCT ROLES | OUTGROWTH | GUIDES CELL | RNA, Small Interfering - genetics | Cell Adhesion Molecules - genetics | Spinal Cord - drug effects | Spinal Cord - metabolism | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Tumor Suppressor Proteins - antagonists & inhibitors | Embryo, Mammalian | Netrin-1 | Spinal Cord - growth & development | Humans | Cell Adhesion Molecules - antagonists & inhibitors | Axons - physiology | Nerve Growth Factors - metabolism | Receptors, Cell Surface - antagonists & inhibitors | MAP Kinase Kinase 4 - metabolism | Isoenzymes - metabolism | Tumor Suppressor Proteins - genetics | HEK293 Cells | MAP Kinase Kinase 4 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 8 - genetics | DCC Receptor | Tumor Suppressor Proteins - metabolism | Isoenzymes - genetics | Mitogen-Activated Protein Kinase 8 - metabolism | Gene Expression Regulation, Developmental - drug effects | Axons - drug effects | Receptors, Cell Surface - metabolism | Cell Adhesion Molecules - metabolism | Chick Embryo | Anthracenes - pharmacology | Animals | Signal Transduction - drug effects | Nerve Growth Factors - genetics | MAP Kinase Kinase 4 - genetics | Nerve Growth Factors - antagonists & inhibitors | Mice | Protein Kinase Inhibitors - pharmacology | Primary Cell Culture | Isoenzymes - antagonists & inhibitors | Receptors, Cell Surface - genetics | Guidance | Neuroscience | Signal Transduction | DSCAM | c-Jun N-terminal Kinase (JNK) | Netrin | Neurobiology | Development | Axon | Neurite Outgrowth
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 06/2018, Volume 138, Issue 6, pp. 1380 - 1390
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33742
Background: N-butylidenephthalide (BP) exhibits antitumor effect in a variety of cancer cell lines. The objective of this study was to obtain additional... 
PATHWAYS | IN-VITRO | UNFOLDED PROTEIN RESPONSE | THERAPY | TRAIL | CYCLIN D1 | TAXOL | BIOLOGY | DEATH | ANGELICA-SINENSIS | CARCINOMA | Transcription Factor CHOP - genetics | Endoribonucleases - genetics | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Apoptosis - drug effects | Humans | Male | Transplantation, Heterologous | Endoribonucleases - antagonists & inhibitors | Mitogen-Activated Protein Kinase 9 - genetics | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Prostatic Neoplasms | RNA Interference | Phthalic Anhydrides - pharmacology | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | G1 Phase Cell Cycle Checkpoints | Mitogen-Activated Protein Kinase 8 - genetics | Antineoplastic Agents - pharmacology | Protein-Serine-Threonine Kinases - metabolism | Endoplasmic Reticulum Stress - drug effects | Endoribonucleases - metabolism | Signal Transduction | Mitogen-Activated Protein Kinase 9 - metabolism | Mitogen-Activated Protein Kinase 8 - metabolism | Protein-Serine-Threonine Kinases - genetics | Transcription Factor CHOP - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinase 9 - antagonists & inhibitors | Cell Line, Tumor | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mice, Inbred NOD | Mice | Transcription Factor CHOP - metabolism | RNA, Small Interfering - metabolism | Proteins | Gene expression | Prostate cancer | Cancer cells | Apoptosis | Biotechnology | Transcription factors | Toxicity | Genes | Clinical trials | Cytotoxicity | Kinases | Cancer therapies | Blockage | Anticancer properties | Buddhism | Rodents | Xenografts | Cell cycle | Oxidation | Drug dosages | G1 phase | Stresses | Medical research | Mortality | JNK protein | siRNA | Tumor cell lines | Stress | Signaling | Androgens | Chemotherapy | DNA microarrays | Cell death | Protein synthesis | Cell lines | Cyclin-dependent kinase inhibitor p27 | Antitumor activity | Gene therapy | Endoplasmic reticulum | Viability | Prostate | CHOP protein | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 01/2006, Volume 66, Issue 1, pp. 212 - 220
Journal Article
Cellular Signalling, ISSN 0898-6568, 01/2013, Volume 25, Issue 1, pp. 150 - 158
JNK signaling functions to induce defense mechanisms that protect organisms against a variety of different situations. The sestrin 2 gene, a p53-regulated... 
Excisanin A | JNK/c-Jun | Sestrin 2 | Autophagy | TARGET | GADD45 | APOPTOSIS | N-TERMINAL KINASE | ENDOPLASMIC-RETICULUM STRESS | KAPPA-B | CELL BIOLOGY | GROWTH | LEUKEMIA-CELLS | RABDOSIA-RUBESCENS | TRANSCRIPTION FACTOR | Phosphorylation | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Microtubule-Associated Proteins - metabolism | Humans | JNK Mitogen-Activated Protein Kinases - metabolism | Mitogen-Activated Protein Kinase 9 - genetics | Autophagy - drug effects | Proto-Oncogene Proteins c-jun - antagonists & inhibitors | Chromatin Immunoprecipitation | RNA Interference | Mitogen-Activated Protein Kinase 8 - genetics | Nuclear Proteins - genetics | Diterpenes - pharmacology | Mitogen-Activated Protein Kinase 9 - metabolism | Proto-Oncogene Proteins c-jun - genetics | Mitogen-Activated Protein Kinase 8 - metabolism | Nuclear Proteins - metabolism | Enzyme Activation - drug effects | Up-Regulation - drug effects | MAP Kinase Signaling System - drug effects | Autophagy-Related Protein 5 | Proto-Oncogene Proteins c-jun - metabolism | Mitogen-Activated Protein Kinase 9 - antagonists & inhibitors | Nuclear Proteins - antagonists & inhibitors | Cell Line, Tumor | RNA, Small Interfering - metabolism | Tumor proteins | Analysis | Cancer | Therapy | Cellular | Pathways | Genes | Activation | Psychological effects | Signalling
Journal Article
International Journal of Molecular Medicine, ISSN 1107-3756, 01/2019, Volume 43, Issue 1, pp. 325 - 335
Fibroblast activation is a key step in the establishment of skin fibrosis induced by acute injury, and it is characterized by the differentiation of plastic... 
Extracellular signal-regulated kinase | Mitogen-activated protein kinase | p38 | Fibroblast | Myofibroblast | Fibrosis | PATHWAYS | MEDICINE, RESEARCH & EXPERIMENTAL | extracellular signal-regulated kinase | TGF-BETA | myofibroblast | PHOSPHORYLATION | P38 MAPK | ERK MAP KINASE | mitogen-activated protein kinase | AMELIORATES RENAL FIBROSIS | fibroblast | II RECEPTOR | SYNTHETIC PEPTIDE | fibrosis | SMAD | EXPRESSION | Transcription, Genetic - drug effects | Fibroblasts - enzymology | Mitogen-Activated Protein Kinase 8 - antagonists & inhibitors | Humans | Extracellular Matrix - metabolism | JNK Mitogen-Activated Protein Kinases - metabolism | p38 Mitogen-Activated Protein Kinases - metabolism | Fibroblasts - metabolism | JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors | Signal Transduction | Extracellular Matrix - drug effects | Mitogen-Activated Protein Kinase 8 - metabolism | Cells, Cultured | Fibroblasts - pathology | Gene Expression Regulation - drug effects | MAP Kinase Signaling System - drug effects | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Receptors, Transforming Growth Factor beta - metabolism | Fibroblasts - drug effects | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Dermis - pathology | Ligands | Protein Kinase Inhibitors - pharmacology | Transforming Growth Factor beta - metabolism | Mitogen-Activated Protein Kinases - metabolism
Journal Article